Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective is to collect data on treatment outcomes (clinical and microbiological
cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with
serious intra-abdominal and hepatobiliary infections in Slovakia.